Assignee
COLBY PHARMACEUTICAL COMPANY
US·1 granted patent·2 pending applications·2 citations·filing 2008–2010
Top patents by PatentIndex Score
3 records- 0173US8383648B2Amelioration of the development of cataracts and other ophthalmic diseasesCOLBY PHARMACEUTICAL COMPANY·Filed 2008·Granted Feb 26, 2013·2 cites·17 claims
- 0235US2011091931A1Methods and Kits for Determining Oxygen Free Radical (OFR) Levels in Animal and Human Tissues as a Prognostic Marker for Cancer and Other PathophysiologiesCOLBY PHARMACEUTICAL COMPANY·Filed 2010·Application pending·0 cites
- 0330US2010297262A1Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and usesCOLBY PHARMACEUTICAL COMPANY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when COLBY PHARMACEUTICAL COMPANY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →